Advertisement
News
Subscribe to MDT Magazine News

Forsyth Institute reels in $20.7M grants for gum disease research

October 18, 2010 8:32 am | by Mass High Tech: The Journal of New England Technology | Comments

The Forsyth Institute, a dental research and teaching organization, has landed a four-year $20.7 million grant from the National Institute of Dental and Craniofacial Research to apply to three research projects aimed at the understanding and treatment of periodontal disease.

TOPICS:

Top U.S. and Korean Companies to Converge at 2010 Global Partnering Day

October 18, 2010 6:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Oct. 18 /- The epicenter of the technology world moves to Basking Ridge, NJ when " 2010 Global Partnering Day ," sponsored by the Korean Trade-Investment Promotion Agency (KOTRA), kicks off later this month. The conference is free for businesses to attend, and it brings together...

TOPICS:

Hospital Council of Western Pennsylvania Announces Foundation Radiology Group as Newest Partner

October 18, 2010 6:34 am | by Bio-Medicine.Org | Comments

PITTSBURGH, Oct. 18 /- Foundation Radiology Group (FRG), the region's premier provider of diagnostic imaging services, is pleased to announce that it has been named the Hospital Council of Western Pennsylvania's newest business partner. FRG is a Pittsburgh-based radiology practice that...

TOPICS:
Advertisement

Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement

October 18, 2010 6:34 am | by Bio-Medicine.Org | Comments

PLANTATION, Fla., Oct. 18 /- Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin...

TOPICS:

Frost & Sullivan: Strategic Partnerships Crucial to Medical Device Success

October 18, 2010 6:33 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Oct. 18 /- Innovation is the key to success for medical device companies in today's economy. However, not only must companies produce superior products, but they must also effectively manage each product's entire lifecycle to achieve success. This includes...

TOPICS:

Sagent Pharmaceuticals Announces Launch of ANEclear Device for Rapid Clearance of Inhaled Anesthetics Following Surgery

October 18, 2010 6:33 am | by Bio-Medicine.Org | Comments

SCHAUMBURG, Ill., Oct. 18 /- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the commercial launch of ANEclear ™ , an easy-to-use, disposable anesthesia recovery device at the American Society of Anesthesia (ASA) meeting in San Diego....

TOPICS:

Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today

October 18, 2010 6:33 am | by Bio-Medicine.Org | Comments

THOUSAND OAKS, Calif., Oct. 18 /- Amgen (Nasdaq: AMGN ) will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal...

TOPICS:

Fenwal Named Exclusive Provider of AccuVein's Award-Winning Vein Illumination Device for Blood and Plasma Centers

October 18, 2010 6:32 am | by Bio-Medicine.Org | Comments

LAKE ZURICH, Ill., Oct. 18 /- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has signed a three-year, exclusive agreement with AccuVein LLC to sell, market and distribute the AccuVein AV300...

TOPICS:
Advertisement

A new order for CPR, spelled C-A-B

October 18, 2010 6:31 am | by EurekAlert | Comments

(American Heart Association) The 2010 AHA Guidelines for CPR and ECC update the 2005 guidelines. When administering CPR, immediate chest compressions should be done first. Untrained lay people are urged to administer hands-only CPR (chest compressions only).

TOPICS:

Federal Register: Medical Device User Fees; Public Meeting; Extension of Comment Period

October 18, 2010 5:30 am | by U.S. Food & Drug Administration | Comments

The FDA is extending to November 1, 2010, the comment period for the notice that appeared in the Federal Register of August 13, 2010 (75 FR 49502).

TOPICS:

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices a...

October 18, 2010 5:30 am | by U.S. Food & Drug Administration | Comments

The FDA is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

TOPICS:

Rural/Metro subsidiaries plan $200M notes offering

October 18, 2010 4:45 am | by The Associated Press | Comments

Rural/Metro Corp., a provider of medical ambulance response services, said Monday that two of its subsidiaries plan to begin a private offering of $200 million senior notes due 2018.The issuers are Rural/Metro Operating Co. LLC and Rural/Metro (Delaware) Inc.The two units also plan to negotiate...

St. Jude agrees to buy AGA Medical for $1.04B

October 18, 2010 3:45 am | by The Associated Press | Comments

St. Jude Medical Inc. says it is buying rival heart device maker AGA Medical Holdings Inc. for $1.04 billion, or $20.80 per share.St. Jude is offering a premium of 41 percent compared to AGA's latest closing price. St. Jude is also taking on $225 million in debt held by AGA, and it says it...

Solta Medical acquires acne laser maker CLRS

October 18, 2010 3:45 am | by The Associated Press | Comments

Skin care device company Solta Medical Inc. said Monday it bought CLRS Technology, a California company that makes a device that treats acne using heat and light.Solta said it agreed to pay off about $1.1 million in CLRS debt and may make additional payments based on CLRS' sales and operating...

Cellectis In-Licenses Induced Pluripotent Stem Cell Technology From iPS Academia Japan

October 18, 2010 12:32 am | by Bio-Medicine.Org | Comments

PARIS and KYOTO, Japan, Oct. 18 /- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading